Headline News

 

GSK’s TESARO provides update on AnaptysBio litigation

Posted on April 28, 2026

GSK’s efimosfermin receives FDA breakthrough therapy and EMA priority medicines designations for MASH

Posted on April 28, 2026

GSK’s bepirovirsen granted priority review and breakthrough therapy designation by FDA for chronic hepatitis B

Posted on April 28, 2026

AbbVie selects Durham, North Carolina for its largest ever manufacturing campus

Posted on April 28, 2026

Dupixent approved as first biologic for young children with uncontrolled chronic spontaneous urticaria

Posted on April 28, 2026

FDA approves Otarmeni the first gene therapy for genetic hearing loss as Regeneron commits to offering it for free

Posted on April 28, 2026

Regeneron strikes deal with white house to cut drug prices, offers gene therapy for free

Posted on April 28, 2026

Etavopivat meets co-primary endpoints in phase 3 HIBISCUS trial for sickle cell disease

Posted on April 21, 2026

Abbott presents new data on Cancerguard multi cancer early detection test at AACR 2026

Posted on April 21, 2026

FDA to convene expert panel to review restrictions on popular peptides

Posted on April 21, 2026

Nuvaxovid demonstrates superior tolerability over mRNA vaccine in head to head study

Posted on April 21, 2026

Tozorakimab meets primary endpoint in Phase III MIRANDA trial for COPD

Posted on April 21, 2026

Ultomiris meets primary endpoint in I CAN phase III trial for IgA nephropathy

Posted on April 21, 2026

FDA grants priority review to Padcev and Keytruda for muscle invasive bladder cancer

Posted on April 21, 2026

Blenrep approved in China for 2L+ relapsed or refractory multiple myeloma

Posted on April 21, 2026